PLAUR and pachyonychia congenita: In this review, we will focus on PET imaging of a new promising molecular target; urokinase-type plasminogen activator receptor (uPAR) in PC as a clinically relevant diagnostic and prognostic imaging biomarker with the possibility of distinguishing indolent tumors from the invasive phenotype.